Skip to main content
. Author manuscript; available in PMC: 2022 Jun 7.
Published in final edited form as: Ann Oncol. 2022 Jan 21;33(4):426–433. doi: 10.1016/j.annonc.2022.01.006

Table 2.

Pathogenic/likely pathogenic germline variants nor detected by tumor-only sequencing according to biological process

Biological process Total Detected Not detected
n % Lower 95% CI Upper 95% CI
HRD 633 587 46 7.3 5.5% 9.6%
DDR 289 252 37 12.8 9.4% 17.2%
MMR 245 199 46 18.8 14.4% 24.1%
Other 139 131 8 5.8 3.0% 11.0%
Total 1306 1169 137 10.5 8.9% 12.3%

CI, confidence interval; HRD, homologous recombination deficiency; DDR, DNA damage response; MMR, mismatch repair.